MJP Associates Inc. ADV purchased a new position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 3,500 shares of the consumer goods maker’s stock, valued at approximately $213,000.
A number of other large investors have also bought and sold shares of the business. Pflug Koory LLC grew its position in Anheuser-Busch InBev SA/NV by 14.0% during the 4th quarter. Pflug Koory LLC now owns 1,621 shares of the consumer goods maker’s stock worth $105,000 after acquiring an additional 199 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Anheuser-Busch InBev SA/NV by 1.1% during the 4th quarter. Franklin Resources Inc. now owns 19,139 shares of the consumer goods maker’s stock worth $1,237,000 after buying an additional 201 shares in the last quarter. Stableford Capital II LLC lifted its holdings in Anheuser-Busch InBev SA/NV by 1.4% during the 4th quarter. Stableford Capital II LLC now owns 16,051 shares of the consumer goods maker’s stock worth $1,046,000 after buying an additional 217 shares in the last quarter. Private Trust Co. NA lifted its holdings in Anheuser-Busch InBev SA/NV by 25.8% during the 4th quarter. Private Trust Co. NA now owns 1,063 shares of the consumer goods maker’s stock worth $69,000 after buying an additional 218 shares in the last quarter. Finally, Armstrong Advisory Group Inc. lifted its holdings in Anheuser-Busch InBev SA/NV by 17.7% during the 4th quarter. Armstrong Advisory Group Inc. now owns 1,692 shares of the consumer goods maker’s stock worth $109,000 after buying an additional 254 shares in the last quarter. 5.53% of the stock is currently owned by institutional investors.
Anheuser-Busch InBev SA/NV Trading Down 0.3 %
Shares of BUD stock traded down $0.18 during trading hours on Friday, reaching $59.06. The company had a trading volume of 1,461,703 shares, compared to its average volume of 1,025,712. The company has a 50 day moving average of $61.71 and a 200 day moving average of $62.24. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.63 and a quick ratio of 0.48. The firm has a market cap of $106.14 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 1.39 and a beta of 1.12. Anheuser-Busch InBev SA/NV has a 1-year low of $51.66 and a 1-year high of $67.49.
Anheuser-Busch InBev SA/NV Increases Dividend
The company also recently disclosed an annual dividend, which was paid on Friday, June 7th. Investors of record on Monday, May 6th were given a $0.8722 dividend. The ex-dividend date was Friday, May 3rd. This represents a dividend yield of 1.1%. This is a boost from Anheuser-Busch InBev SA/NV’s previous annual dividend of $0.61. Anheuser-Busch InBev SA/NV’s dividend payout ratio is currently 27.31%.
Analyst Upgrades and Downgrades
Separately, TD Cowen reduced their price objective on Anheuser-Busch InBev SA/NV from $67.00 to $65.00 and set an “outperform” rating on the stock in a report on Tuesday, March 5th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $72.13.
Get Our Latest Analysis on BUD
Anheuser-Busch InBev SA/NV Company Profile
Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.
Featured Stories
- Five stocks we like better than Anheuser-Busch InBev SA/NV
- What Are Trending Stocks? Trending Stocks Explained
- McDonald’s Stock: Balancing Value and Innovation
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 6/17 – 6/21
- What is the Shanghai Stock Exchange Composite Index?
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.